PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Blue Cross & Blue Shield of MississippiAll Plans · Coverage · Medical Policy · Oncology, Radiation Oncology, NeurosurgeryMedium impact

Intensity-Modulated Radiotherapy (IMRT): Central Nervous System Tumors

Effective date
Not stated in the notice
Identified
Jun 20, 2026

Summary

IMRT may be considered medically necessary for individuals with malignant or benign brain tumors when the tumor is proximate to organs at risk (brain stem, spinal cord, cochlea, and eye structures) and 3-dimensional conformal radiotherapy planning cannot meet dose-volume constraints for normal tissue tolerance. Hippocampal-avoiding IMRT may be considered medically necessary for individuals with brain tumor metastases outside a 5-mm margin around either hippocampus and expected survival of 4 months or more. IMRT is considered investigational for tumors of the central nervous system for all other indications.

Get alerts when payers change rules like this one

We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.

Get Blue Cross & Blue Shield of Mississippi alertsPolicy Monitoring is free. No card required.

What to do

Action · 5 steps
01Billing team: bill IMRT for brain tumors as medically necessary only when the tumor is proximate to organs at risk and 3-dimensional conformal radiotherapy planning cannot meet dose-volume constraints for normal tissue tolerance.
02Bill hippocampal-avoiding IMRT as medically necessary for brain tumor metastases outside a 5-mm margin around either hippocampus when expected survival is 4 months or more.
03Bill IMRT for all other central nervous system tumor indications as investigational.
04Bill the covered codes 77301, 77338, 77385, 77386, G6015, and G6016 with the central nervous system diagnosis codes listed in the code reference, and only when the procedure is performed according to the policy section.
05Dosimetry plans may be reviewed to demonstrate that 3-dimensional conformal radiotherapy would exceed tolerance doses to structures at risk.

Codes mentioned

77301773387738577386G6015G6016C70.0C70.9C71.0C71.9C72.0C72.9C79.31C79.32C79.40C79.49D33.0D33.2

Original notice

Intensity-Modulated Radiotherapy (IMRT): Central Nervous System Tumors
bcbsms.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account